We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

The Ribavirin Pregnancy Registry (RPR)

This study is currently recruiting participants.
Verified January 2017 by INC Research
ClinicalTrials.gov Identifier:
First Posted: June 17, 2005
Last Update Posted: January 24, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Aurobindo Pharma
Genentech, Inc.
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Kadmon Pharmaceuticals
Information provided by (Responsible Party):
INC Research
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2025
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):